Date
23 January 2018
Listen: Nieuws & Co.
Martijn van de Zande of Nieuws & Co. delves into the results of the AMR Benchmark with Dr Wiel de Lange of UMCG hospital, Marijn Verhoef of the Access to Medicine Foundation, and health reporter Rinke van de Brink.
Martijn van de Zande of Nieuws & Co. reports on how Johnson & Johnson sets the right example for other companies to follow. The interview includes a discussion with lung doctor Wiel de Lange from the UMCG hospital on the treatment of multidrug-resistant tuberculosis. Marijn Verhoef, researcher from the Access to Medicine Foundation, discusses the key findings of the AMR Benchmark, which is followed up by health reporter Rinke van de Brink, who reports on the serious threat of resistant bacteria.